| RS750268044 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS750268759 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS750269236 |
GHSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature due to growth hormone secretagogue receptor deficiency, Short stature due to growth hormone secretagogue receptor deficiency |
| RS750269576 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Neuropathy |
| RS750272621 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS750273092 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS750273506 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS750274275 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS750275170 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS750275456 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS750276279 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS750277154 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS750278602 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, TTN-related disorder |
| RS750279128 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS750279232 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Alzheimer disease |
| RS750279410 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
RECON progeroid syndrome, RECON progeroid syndrome |
| RS750279631 |
AKT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Inborn genetic diseases |
| RS750279642 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS750280055 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS750280281 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal-hepatic-pancreatic dysplasia 1, Nephronophthisis |
| RS750280339 |
CTSB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS75028043 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS750280554 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS750281602 |
SLC39A14
|
Health Risk |
Pathogenic |
Hypermanganesemia with dystonia 2, Hypermanganesemia with dystonia 2 |
| RS750281789 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS750282687 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS750284532 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS750284952 |
SRPX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS750285313 |
NDUFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS750285967 |
TMPRSS15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS750286012 |
LETM1
|
Health Risk |
Pathogenic |
LETM1-associated clinical spectrum with predominant nervous system involvement, Neurodegeneration |
| RS750286179 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS750286630 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, 3 beta-Hydroxysteroid dehydrogenase deficiency |
| RS750287289 |
INVS
|
Health Risk |
Likely pathogenic |
Infantile nephronophthisis, Infantile nephronophthisis |
| RS750287727 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS75028796 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS750289236 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS750290204 |
CSGALNACT1
|
Health Risk |
Pathogenic |
— |
| RS750291363 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intervertebral disc disorder, Hearing loss |
| RS750291418 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS750291645 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS750291697 |
KHDRBS1
|
Health Risk |
Likely pathogenic |
Premature ovarian failure, Premature ovarian failure |
| RS750292508 |
RASGRP1
|
Health Risk |
Pathogenic |
— |
| RS750292546 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C |
| RS750293380 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS750294252 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS750294275 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS750294638 |
GJA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculodentodigital dysplasia, autosomal recessive |
| RS750296552 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS750296853 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Fibromatosis |
| RS750297310 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS750298083 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS750298260 |
GOSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS75030001 |
RET
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 2A, Familial medullary thyroid carcinoma |
| RS750301200 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Inborn genetic diseases |
| RS750302536 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1F |
| RS750302661 |
CR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS750303653 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS750303767 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS750305530 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS750306743 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS750308686 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS750308729 |
YIF1B
|
Health Risk |
Pathogenic |
Kaya-Barakat-Masson syndrome, Kaya-Barakat-Masson syndrome |
| RS750309571 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS750309713 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS750311213 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS750312986 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS75031300 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS750313305 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS750315709 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KAT6A-related disorder |
| RS750315914 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS750318549 |
ASXL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bohring-Opitz syndrome, Abnormal brain morphology |
| RS750318685 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS750318922 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS750319167 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS750319602 |
COPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune interstitial lung disease-arthritis syndrome, Inborn genetic diseases |
| RS750320516 |
FRMD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Nystagmus 1, congenital |
| RS750321216 |
SPAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia |
| RS750321557 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS750322384 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS750323164 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS750323424 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS750323428 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS750323931 |
AFF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Inborn genetic diseases |
| RS750324091 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS750324117 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS750324212 |
ANTXR2
|
Health Risk |
Pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS750325275 |
CLASP1;CLASP1-AS1;RNU4ATAC
|
Health Risk |
Pathogenic/Likely pathogenic |
Roifman syndrome, Osteodysplastic primordial dwarfism |
| RS750325388 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS750325978 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS750326578 |
GATAD2B
|
Health Risk |
Conflicting classifications of pathogenicity |
GATAD2B-related disorder, GATAD2B-related disorder |
| RS750326619 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS750326949 |
STIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stormorken syndrome, Combined immunodeficiency due to STIM1 deficiency |
| RS750327994 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS750328754 |
LAMA2
|
Health Risk |
Pathogenic |
Abnormality of the musculature, LAMA2-related muscular dystrophy |
| RS750328756 |
C2CD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome type 14, Orofaciodigital syndrome type 14 |
| RS750329103 |
CHRNA1
|
Health Risk |
Pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS750329453 |
SCN4B
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 10, Cardiovascular phenotype |
| RS750329563 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 11 |
| RS750330550 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 2, Long QT syndrome |